NCT01830764View on ClinicalTrials.gov

Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Acne Vulgaris
Interventions
DRUG

Red Light (PDT)

LTS, 0.3% applied topically followed by red light dose (75 J/cm2 or 150 J/cm2)

Trial Locations (1)

07652

TKL Research Inc (Research Clinics Division), Paramus

Sponsors

Lead Sponsor

Dermira, Inc.
All Listed Sponsors
lead

Dermira, Inc.

INDUSTRY

NCT01830764 - Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers | Biotech Hunter | Biotech Hunter